HLA class I antigen abnormalities and immune escape by malignant cells
- 1 February 2002
- journal article
- review article
- Published by Elsevier in Seminars in Cancer Biology
- Vol. 12 (1) , 3-13
- https://doi.org/10.1006/scbi.2001.0404
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Non-expression of HLA-B*5111N is caused by an insertion into the cytosine island at exon 4 creating a frameshift stop codonTissue Antigens, 2001
- Expression analysis of classic and non-classic HLA molecules before interferon alfa-2b treatment of melanomaThe Lancet, 2000
- Melanomas and melanoma cell lines do not express HLA‐G, and the expression cannot be induced by γIFN treatmentTissue Antigens, 2000
- Mutations of the β2‐microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptidesTissue Antigens, 1998
- beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma.Journal of Clinical Investigation, 1998
- Implications for immunosurveillance of altered HLA class I phenotypes in human tumoursImmunology Today, 1997
- Mechanisms of loss of HLA class I expression on colorectal tumor cellsTissue Antigens, 1996
- Loss of an HLA haplotype in pancreas cancer tissue and its corresponding tumor derived cell lineTissue Antigens, 1996
- Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinial relevanceImmunology Today, 1995
- Immune surveillance in colorectal carcinomaNature Genetics, 1995